MACROGENICS, INC. Increase (Decrease) in Accounts Receivable
MACROGENICS, INC. (MGNX) reported Increase (Decrease) in Accounts Receivable of $23.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-14
- MACROGENICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $25.95M, a 1203.97% increase year-over-year.
- MACROGENICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$2.95M, a 147.28% decline year-over-year.
- MACROGENICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$55.86M.
- MACROGENICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $56.70M, a 2114.77% increase year-over-year.
- MACROGENICS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $9.06M.
- MACROGENICS, INC. increase (decrease) in accounts receivable for fiscal 2024 was -$6.06M.
- MACROGENICS, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$45.85M, a 200.04% decline from fiscal 2022.
- MACROGENICS, INC. increase (decrease) in accounts receivable for fiscal 2022 was $45.84M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $25.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $23.00M 10-Q · filed 2026-08-14 | -$32.86M derived: sum of 3 quarters · filed 2026-08-14 | $23.84M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$2.95M 10-Q · filed 2026-05-13 | -$58.80M derived: sum of 2 quarters · filed 2026-05-13 | -$2.11M derived: sum of 3 quarters · filed 2026-05-13 | -$117.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$55.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $840.00K derived: sum of 2 quarters · filed 2026-03-09 | $2.83M derived: sum of 3 quarters · filed 2026-08-14 | $9.06M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $56.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $58.69M derived: sum of 2 quarters · filed 2026-08-14 | $64.92M 10-Q · filed 2025-11-12 | $60.48M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $8.22M 10-Q · filed 2026-08-14 | $3.78M derived: sum of 3 quarters · filed 2026-08-14 | $6.34M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $6.23M 10-Q · filed 2026-05-13 | $1.79M derived: sum of 2 quarters · filed 2026-05-13 | $4.35M derived: sum of 3 quarters · filed 2026-05-13 | $3.32M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$1.88M derived: sum of 2 quarters · filed 2026-03-09 | -$2.91M derived: sum of 3 quarters · filed 2026-03-09 | -$6.06M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $2.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.53M derived: sum of 2 quarters · filed 2025-11-12 | -$1.62M 10-Q · filed 2025-11-12 | -$16.56M derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2024-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$4.18M 10-Q · filed 2025-08-14 | -$19.12M derived: sum of 3 quarters · filed 2026-03-09 | -$219.00K derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2024-03-31 | -$3.15M 10-Q · filed 2025-05-13 | -$18.09M derived: sum of 2 quarters · filed 2026-03-09 | $809.00K derived: sum of 3 quarters · filed 2026-03-09 | -$28.94M derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2023-12-31 | -$14.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $3.96M derived: sum of 2 quarters · filed 2026-03-09 | -$25.79M derived: sum of 3 quarters · filed 2026-03-09 | -$45.85M 10-K · filed 2026-03-09 | |||
| 2023-09-30 | $18.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$10.85M derived: sum of 2 quarters · filed 2024-11-05 | -$30.91M 10-Q · filed 2024-11-05 | $11.47M derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2023-06-30 | -$29.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$49.81M 10-Q · filed 2024-08-06 | -$7.43M derived: sum of 3 quarters · filed 2025-03-20 | -$11.97M derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2023-03-31 | -$20.06M 10-Q · filed 2024-05-09 | $22.32M derived: sum of 2 quarters · filed 2025-03-20 | $17.77M derived: sum of 3 quarters · filed 2025-03-20 | $21.25M derived: sum of 4 quarters · filed 2025-03-20 | |||
| 2022-12-31 | $42.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $37.84M derived: sum of 2 quarters · filed 2025-03-20 | $41.32M derived: sum of 3 quarters · filed 2025-03-20 | $45.84M 10-K · filed 2025-03-20 | |||
| 2022-09-30 | -$4.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$1.07M derived: sum of 2 quarters · filed 2023-11-06 | $3.45M 10-Q · filed 2023-11-06 | $78.00K derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2022-06-30 | $3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $8.00M 10-Q · filed 2023-08-09 | $4.63M derived: sum of 3 quarters · filed 2024-03-07 | -$26.86M derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2022-03-31 | $4.52M 10-Q · filed 2023-05-09 | $1.15M derived: sum of 2 quarters · filed 2024-03-07 | -$30.34M derived: sum of 3 quarters · filed 2024-03-07 | $7.76M derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2021-12-31 | -$3.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$34.86M derived: sum of 2 quarters · filed 2024-03-07 | $3.24M derived: sum of 3 quarters · filed 2024-03-07 | -$12.70M 10-K · filed 2024-03-07 | |||
| 2021-09-30 | -$31.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $6.61M derived: sum of 2 quarters · filed 2022-11-03 | -$9.32M 10-Q · filed 2022-11-03 | -$5.02M derived: sum of 4 quarters · filed 2023-03-15 | |||
| 2021-06-30 | $38.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $22.17M 10-Q · filed 2022-08-08 | $26.47M derived: sum of 3 quarters · filed 2023-03-15 | $26.04M derived: sum of 4 quarters · filed 2023-03-15 | |||
| 2021-03-31 | -$15.93M 10-Q · filed 2022-05-03 | -$11.63M derived: sum of 2 quarters · filed 2023-03-15 | -$12.06M derived: sum of 3 quarters · filed 2023-03-15 | -$4.66M derived: sum of 4 quarters · filed 2023-03-15 | |||
| 2020-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $3.88M derived: sum of 2 quarters · filed 2023-03-15 | $11.28M derived: sum of 3 quarters · filed 2023-03-15 | $10.34M 10-K · filed 2023-03-15 | |||
| 2020-09-30 | -$428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $6.97M derived: sum of 2 quarters · filed 2021-11-02 | $6.03M 10-Q · filed 2021-11-02 | $9.27M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $7.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $6.46M 10-Q · filed 2021-07-29 | $9.70M derived: sum of 3 quarters · filed 2022-02-24 | $13.59M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | -$938.00K 10-Q · filed 2021-04-29 | $2.30M derived: sum of 2 quarters · filed 2022-02-24 | $6.19M derived: sum of 3 quarters · filed 2022-02-24 | $5.69M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $7.13M derived: sum of 2 quarters · filed 2022-02-24 | $6.63M derived: sum of 3 quarters · filed 2022-02-24 | -$16.84M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $3.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $3.39M derived: sum of 2 quarters · filed 2020-11-04 | -$20.08M 10-Q · filed 2020-11-04 | -$11.47M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | -$503.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$23.97M 10-Q · filed 2020-07-31 | -$15.36M derived: sum of 3 quarters · filed 2021-02-25 | -$12.22M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | -$23.47M 10-Q · filed 2020-05-05 | -$14.86M derived: sum of 2 quarters · filed 2021-02-25 | -$11.72M derived: sum of 3 quarters · filed 2021-02-25 | -$1.17M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $8.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $11.75M derived: sum of 2 quarters · filed 2021-02-25 | $22.30M derived: sum of 3 quarters · filed 2021-02-25 | $15.94M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $13.69M derived: sum of 2 quarters · filed 2019-11-06 | $7.33M 10-Q · filed 2019-11-06 | $18.78M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $10.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $4.19M 10-Q · filed 2019-07-31 | $15.64M derived: sum of 3 quarters · filed 2020-02-25 | $15.85M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | -$6.36M 10-Q · filed 2019-05-01 | $5.09M derived: sum of 2 quarters · filed 2020-02-25 | $5.29M derived: sum of 3 quarters · filed 2020-02-25 | $5.19M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $11.45M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $11.65M derived: sum of 2 quarters · filed 2020-02-25 | $11.55M derived: sum of 3 quarters · filed 2020-02-25 | $10.88M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $101.00K derived: sum of 2 quarters · filed 2018-11-07 | -$570.00K 10-Q · filed 2018-11-07 | -$814.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | -$102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$773.00K 10-Q · filed 2018-08-07 | -$1.02M derived: sum of 3 quarters · filed 2019-02-26 | -$76.38M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | -$671.00K 10-Q · filed 2018-05-07 | -$915.00K derived: sum of 2 quarters · filed 2019-02-26 | -$76.28M derived: sum of 3 quarters · filed 2019-02-26 | -$418.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | -$244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$75.61M derived: sum of 2 quarters · filed 2019-02-26 | $253.00K derived: sum of 3 quarters · filed 2019-02-26 | $1.54M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | -$75.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $497.00K derived: sum of 2 quarters · filed 2017-11-08 | $1.78M 10-Q · filed 2017-11-08 | $264.00K derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $75.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $77.15M 10-Q · filed 2017-08-02 | $75.63M derived: sum of 3 quarters · filed 2018-02-27 | $74.04M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $1.29M 10-Q · filed 2017-05-03 | -$233.00K derived: sum of 2 quarters · filed 2018-02-27 | -$1.82M derived: sum of 3 quarters · filed 2018-02-27 | $792.00K derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$3.11M derived: sum of 2 quarters · filed 2018-02-27 | -$495.00K derived: sum of 3 quarters · filed 2018-02-27 | -$1.71M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | -$1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $1.02M derived: sum of 2 quarters · filed 2016-11-02 | -$191.00K 10-Q · filed 2016-11-02 | -$2.57M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $1.40M 10-Q · filed 2016-08-03 | -$981.00K derived: sum of 3 quarters · filed 2017-02-28 | $1.69M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | -$1.22M 10-Q · filed 2016-05-04 | -$3.60M derived: sum of 2 quarters · filed 2017-02-28 | -$926.00K derived: sum of 3 quarters · filed 2017-02-28 | -$27.00K derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $290.00K derived: sum of 2 quarters · filed 2017-02-28 | $1.19M derived: sum of 3 quarters · filed 2017-02-28 | $931.00K 10-K · filed 2017-02-28 | |||
| 2014-09-30 | $2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $3.57M derived: sum of 2 quarters · filed 2015-11-04 | $3.31M 10-Q · filed 2015-11-04 | $3.03M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $899.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $641.00K 10-Q · filed 2015-08-05 | $364.00K derived: sum of 3 quarters · filed 2016-02-29 | -$1.51M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$258.00K 10-Q · filed 2015-05-06 | -$258.28K 10-Q · filed 2014-05-06 | -$535.00K derived: sum of 2 quarters · filed 2016-02-29 | -$2.41M derived: sum of 3 quarters · filed 2016-02-29 | -$575.90K derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | -$277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$2.15M derived: sum of 2 quarters · filed 2016-02-29 | -$317.90K derived: sum of 3 quarters · filed 2016-02-29 | -$42.00K 10-K · filed 2016-02-29 | -$42.20K 10-K · filed 2014-03-20 | ||
| 2013-09-30 | -$1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$40.91K derived: sum of 2 quarters · filed 2014-11-12 | $235.00K 10-Q · filed 2014-11-12 | $235.06K 10-Q · filed 2013-11-12 | -$3.83M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2013-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $2.11M 10-Q · filed 2014-08-05 | -$1.96M derived: sum of 3 quarters · filed 2015-03-03 | ||||
| 2013-03-31 | $275.90K 10-Q · filed 2014-05-06 | -$3.79M derived: sum of 2 quarters · filed 2015-03-03 | |||||
| 2012-12-31 | -$4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | -$1.35M 10-K · filed 2015-03-03 | -$1.35M 10-K · filed 2014-03-20 | ||||
| 2012-09-30 | $2.71M 10-Q · filed 2013-11-12 | ||||||
| 2011-12-31 | -$12.55M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |